Spot Health

Market position

Early-stage, seed-funded participant in the at-home diagnostics/telehealth infrastructure segment. Seedtable categorizes the company under Medtech, Healthtech, Diagnostics, Telehealth and Healthcare, and ranks it among a small set of Cincinnati medtech and diagnostics startups.

Positions itself as a turnkey, fully white-labeled alternative to building an in-house testing operation: partners keep their own branding on packaging and digital tools while Spot absorbs kit fulfillment, logistics, regulatory/physician-order handling and lab integrations, with stated launch timelines of days rather than months.

Technology

An API-based platform through which partner brands order tests, plus integrations with partner laboratories and tooling to deliver results, reference ranges and medically-vetted interpretations into the partner's customer-facing app. The company states the service is HIPAA compliant and publishes developer documentation.

Go-to-market

Direct sales led from the website, which routes prospects to a scheduled discovery call or contact form; developer documentation supports technical evaluation. The company also recruits publicly through the Y Combinator jobs directory.

Consumer and remote-care health brands: supplement, fitness and meal-plan companies seeking personalization; telehealth and patient-care providers monitoring chronic conditions or screening for cancers and STIs at home; and brands running efficacy studies to support evidence-based product claims.

Geography

Headquartered in Cincinnati, Ohio, United States, with U.S.-focused operations; job listings are for Cincinnati or remote U.S. roles. Service coverage accounts for varying U.S. state requirements for physician orders.

History

Established in 2021 in Cincinnati, Ohio. The company joined Y Combinator's Winter 2022 batch, announced in the batch introduction covering 414 companies, and a seed round with Y Combinator is recorded as of 1 January 2022. Third-party trackers continued to list the company as active with open roles as of the most recent updates.

Risks & controversies

No controversies are reported in the sources. Notable gaps: total funding is undisclosed, revenue and headcount figures are third-party estimates, and no customers, partners or laboratory names are disclosed. Operations depend on partner laboratories and on U.S. state-level requirements for physician authorization.